Peter Lauer

A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

John N. Feder, Andreas Gnirke, Zenta Tsuchihashi et al. · Nature Genetics · 1996 · 3.7K citations

Histocompatibility, Immunogenetics, Autoimmune Disease +11

TOX is a critical regulator of tumour-specific T cell differentiation

Andrew Scott, Friederike Dündar, Paul Zumbo et al. · Nature · 2019 · 1K citations · Full text

Cancer Immunosurveillance, Lymphocyte Development, T-regulatory Cell +9

Chromatin states define tumour-specific T cell dysfunction and reprogramming

Mary Philip, Lauren Fairchild, Liping Sun et al. · Nature · 2017 · 879 citations · Full text

Chromatin, Chromatin Remodeling, Chromatin States +4

Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis

Andrea Schietinger, Mary Philip, Varintra E. Krisnawan et al. · Immunity · 2016 · 699 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, T-regulatory Cell +10

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

Juan Fu, David B. Kanne, Meredith L. Leong et al. · Science Translational Medicine · 2015 · 681 citations